Answer
Yes, ospemifene is contraindicated in suspected or active sex-hormone dependent malignancy, including endometrial cancer.
Sources for this answer
- Senshio 60 mg film-coated tabletsShionogi · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked